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Abstract 
Synthesis of Metal Complexes 
The nitrogen and oxygen-containing tetradentate chelating ligand SALEN (2,2'-
Ethylenebis(nitrilomethylidene)diphenol, N,N'-Ethylenebis(salicylimine) was used to 
synthesize metal complexes with a square planar N2O2-donor coordination 
environment. We explored the first-row transition metal salts: Fe(II), Cu(II), Ni(II), 
Co(II), Mn(II) and Zn(II), which produced several stable metal complexes.  
Our goal is to understand more about the active sites 
and catalytic mechanism of Cysteine Dioxygenase 
and Quercetin Dioxygenase, which are both important 
dioxygenase enzymes.  Dioxygenase Enzymes 
catalyze critical reactions in the body and the 
environment.   
Our research involves synthesis, structural and 
electronic characterization of model molecules that 
have one or more significant properties of a 
metalloenzyme active site.   
The aim of this work is to synthesize Iron (II) Salen 
and Nickel (II) Salen coordination complexes and 
characterize them by using Mass Spectrometry, 
UV/Vis and IR Spectroscopy.  Reactivity studies with 
cysteine and quercetin will be explored.   
 
Background 
Cysteine dioxygenase (CDO) catalyzes the oxidation of L-cysteine to cysteine sulfinic acid (Scheme 1), 
an important biochemical pathway used for oxidation of cysteine to sulfate as well as an important step 
in taurine biosynthesis. Toxic bioaccumulation of cysteine has been associated with neurological 
disorders such as motor neuron disease, Alzheimer’s and Parkinson’s disease, as well as rheumatoid 
arthritis and liver disease. The CDO enzyme is considered to be a potential drug target in therapies 
addressing imbalances in the metabolism of cysteine. 
The active site of cysteine dioxygenase (Figure 2) from Mus musculus contains an iron(II) center with 
His-86, -88 and -140 as the coordinating amino acid residues as well as a cysteinyl-tyrosine linkage in 
the vicinity of the active site.4 
 
 
 
 
 
Quercetin dioxygenase (QDO) catalyzes the oxidation of two carbon-carbon bonds of quercetin, with 
release of carbon monoxide and a corresponding depside (Scheme 2). Bacteria use enzymes like QDO 
to degrade aromatic compounds in the environment and quercetin has been shown to exhibit anti-
inflammatory and anti-carcinogenic properties in the human body. 
The active site structures of Aspergillus japonicus quercetin 2,3 dioxygenase1 contains a Cu(II) center 
with three histidine residues and one glutamate residue and from YxaG, from Bacillus subtilis, the 
copper(II) is replaced by iron(II), but has similar amino acid residues (Figure 3).   
Fig 1. Ribbon illustration (left) and active site (right) of quercetin 2,3 
dioxygenase from Aspergilus japonicus where quercetin is bound to 
the copper (II) center.1  Figure 3.  
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Characterization of Ni(II)-Salen and Fe(III)-Salen  
The Ni(II)-salen afforded orange needles upon crystallization in dichloromethane and 
diethyl ether which agrees with a previous report of this compound.6 
The Fe(III)-salen afforded a burgundy crayon-like solid after re-crystallization 
attempts.    
Comparison of the spectroscopic, redox and magnetic properties of these metal-
bound complexes will allow us to directly probe the effect of the nitrogen and oxygen 
containing amino acids in the active site as well as the 3-His structural constraints.  
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IR Spectra by Joe Heimann 
νC=N = 1622 cm
-1 
UV/Vis Spectrum of Ni(II)-Salen, orange crystals in 
dichloromethane, at 25˚C 
λ = 420 nm 
λ 330= nm 
Synthesis of Ligand 
Apo-salen was synthesized according to literature procedures and was 
characterized by IR (shown) and 1H NMR (not shown) spectroscopy. 
UV/Vis Spectrum of Fe(III)-Salen, brown solid 
dissolved in dichloromethane, at 25˚C 
λ = 330nm 
λ = 270nm 
νC=N = 1609 cm
-1 
Scheme 2.  
Scheme 1.  
Figure 2.  
